These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15073160)

  • 1. Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea.
    Wilcox MH
    J Antimicrob Chemother; 2004 May; 53(5):882-4. PubMed ID: 15073160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea.
    McPherson S; Rees CJ; Ellis R; Soo S; Panter SJ
    Dis Colon Rectum; 2006 May; 49(5):640-5. PubMed ID: 16525744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recurrent Clostridium difficile enterocolitis].
    Bergamin B; Hess T; Jost R; Ballmer PE; Imoberdorf R
    Schweiz Med Wochenschr; 2000 Nov; 130(44):1681-4. PubMed ID: 11103440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin for resistant Clostridium difficile infection.
    Murphy C; Vernon M; Cullen M
    Age Ageing; 2006 Jan; 35(1):85-6. PubMed ID: 16303776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii.
    Surawicz CM; McFarland LV; Greenberg RN; Rubin M; Fekety R; Mulligan ME; Garcia RJ; Brandmarker S; Bowen K; Borjal D; Elmer GW
    Clin Infect Dis; 2000 Oct; 31(4):1012-7. PubMed ID: 11049785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment strategies for C. difficile associated diarrhea.
    Stepan C; Surawicz CM
    Acta Gastroenterol Latinoam; 2007 Sep; 37(3):183-91. PubMed ID: 17955730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system.
    Belmares J; Gerding DN; Parada JP; Miskevics S; Weaver F; Johnson S
    J Infect; 2007 Dec; 55(6):495-501. PubMed ID: 17983659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea.
    Juang P; Skledar SJ; Zgheib NK; Paterson DL; Vergis EN; Shannon WD; Ansani NT; Branch RA
    Am J Infect Control; 2007 Mar; 35(2):131-7. PubMed ID: 17327194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
    Zar FA; Bakkanagari SR; Moorthi KM; Davis MB
    Clin Infect Dis; 2007 Aug; 45(3):302-7. PubMed ID: 17599306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii.
    Surawicz CM; McFarland LV; Elmer G; Chinn J
    Am J Gastroenterol; 1989 Oct; 84(10):1285-7. PubMed ID: 2679049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pseudomembranous colitis: report of four cases].
    Solana de Lope J; Aguilera E; Vinageras JI; Pérez Manauta J
    Rev Gastroenterol Mex; 1997; 62(2):113-6. PubMed ID: 9471661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease.
    McFarland LV
    Am J Gastroenterol; 2006 Apr; 101(4):812-22. PubMed ID: 16635227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.
    Johnson S
    J Infect; 2009 Jun; 58(6):403-10. PubMed ID: 19394704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
    Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The approach to recurrent infections with Clostridium difficile].
    Paz Z; Altman A
    Harefuah; 2008 Nov; 147(11):864-5, 942. PubMed ID: 19264004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clostridium-difficile-associated diarrhea].
    Bujanda L; Cosme A
    Gastroenterol Hepatol; 2009 Jan; 32(1):48-56. PubMed ID: 19174100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes.
    McEllistrem MC; Carman RJ; Gerding DN; Genheimer CW; Zheng L
    Clin Infect Dis; 2005 Jan; 40(2):265-72. PubMed ID: 15655746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic criteria in Clostridium difficile colitis.
    Ramaswamy R; Grover H; Corpuz M; Daniels P; Pitchumoni CS
    Am J Gastroenterol; 1996 Mar; 91(3):460-4. PubMed ID: 8633491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease.
    McFarland LV; Surawicz CM; Greenberg RN; Fekety R; Elmer GW; Moyer KA; Melcher SA; Bowen KE; Cox JL; Noorani Z
    JAMA; 1994 Jun 22-29; 271(24):1913-8. PubMed ID: 8201735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis.
    Byrn JC; Maun DC; Gingold DS; Baril DT; Ozao JJ; Divino CM
    Arch Surg; 2008 Feb; 143(2):150-4; discussion 155. PubMed ID: 18283139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.